Beryl Capital Management LLC - 16 May 2025 SCHEDULE 13G Report for Inozyme Pharma, Inc. Common Stock (INZY)

Filing Manager
Beryl Capital Management LLC
Reporting Manager
Beryl Capital Management LLC
Security
Inozyme Pharma, Inc. Common Stock
Symbol
INZY
Shares outstanding
64.5M shares
Disclosed Ownership
6.32M shares
Ownership
9.8%
Form type
SCHEDULE 13G
Filing time
23 May 2025, 16:22:54 UTC
Date of event
16 May 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Beryl Capital Management LLC 9.8% 6.32M 0 6.32M /s/ Andrew Nelson Chief Operating Officer
Beryl Capital Management LP 9.8% 6.32M 0 6.32M /s/ Andrew Nelson Chief Operating Officer of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP
Beryl Capital Partners II LP 7.9% 5.09M 0 5.09M /s/ Andrew Nelson COO of Beryl Capital Management LLC, General Partner of Beryl Capital Management LP, General Partner of Beryl Capital Partners II LP
David A. Witkin 9.8% 6.32M 0 6.32M /s/ David A. Witkin Reporting person